Mouse S100A8/S100A9 quantitates mouse S100A8/S100A9 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse S100A8/S100A9.
Accession number
60B8Ag; AI323541; AW546964; B8Ag; BEE11; BEE22; Caga; Cagb; calgranulin A; calgranulin B; calgranulin-A; calgranulin-B; calprotectin; calprotectin subunit L1H; calprotectin subunit L1L; CFAG; CGLA; CGLB; chemotactic cytokine CP-10; chemotactic protein S100; CP-10; cystic fibrosis antigen; EGK_01322; EGK_21438; GAGB; intracellular calcium binding protein (MRP14); L1AG; heavy chain of leukocyte complex L1; light chain of leukocyte complex L1; LIAG; LOC100735514; LOC532569 protein; MA387; MAC387; protein 8 linked to the inhibitory factor of macrophage migration; MIF; protein 14 linked to migration inhibitor; protein 8 linked to migration inhibitor; Mrp14; MRP-14; MRP8; MRP-8; Myeloid protein 14; neutrophil cytosolic protein 23 kDa; cytos protein
Dose range
0.65 to 150 ng/ml
Sensitivity of the dosage
0.65 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Mouse S100A8/S100A9 quantitates mouse S100A8/S100A9 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse S100A8/S100A9.
Mouse S100A8/S100A9 quantitates mouse S100A8/S100A9 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse S100A8/S100A9.
The heterocomplex S100A8/A9, also known as the MRP-8/MRP-14 complex or calprotectin, comprises 60% of the cytoplasmic protein fraction of circulating polymorphonuclear granulocytes and is also found in ileum monocytes, macrophages and tissue eosinophils. Peripheral blood monocytes carry the antigen extracellularly and intracellularly, and neutrophils only intracellularly. The S100A8/A9 complex has antibacterial, antifungal, immunomodulatory and antiproliferative effects. In addition, it is a powerful chemotactic factor for neutrophils. Plasma concentrations are high in diseases associated with increased neutrophil activity, such as chronic inflammatory bowel disease. Granocytes end their existence after transmigration through the intestinal wall. Therefore, calprotectin is also detectable in faecal matter. High levels of calprotectin were observed in body fluids such as plasma, saliva, gingival crevicular fluid, stools and synovial fluid during infection and inflammatory conditions.
Sensitivity
Sensitivity of the dosage: 0.65 ng/ml.
Measurement range
Dose range: 0.65 to 150 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: Calprotectin.
Samples
Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).